EVONILE PHARMA Latest Share Price (EVONILE)
TODAY IN ONE LINE
EVONILE rose 2.4%, in line with Nifty's 2.0% move, reaching near its 52-week high of ₹1738.0.
With a market cap of ₹4,232.74 Cr., it trades at a P/E of N/A. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
EVONILE PHARMA flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●Virtually Debt-FreeVery low Debt-to-Equity of 0.00x
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
No red flags identified
Latest EVONILE PHARMA News
What changed recently?
Recent events, corporate actions, and announcements.
EVONILE PHARMA valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for EVONILE PHARMA, framed against the sector median so the premium or discount is obvious at a glance.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
EVONILE PHARMA technical analysis: indicators, pivots and CPR.
Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for EVONILE PHARMA — derived from the latest tape, not yesterday's close.
EVONILE PHARMA last traded at ₹1,758.4 with an intraday range of ₹1,695–₹1,785 — latest indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Last: ₹1758.40| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 1977.27 | +218.87 | +12.45% |
| R3 | 1887.27 | +128.87 | +7.33% |
| R2 | 1836.13 | +77.73 | +4.42% |
| R1 | 1797.27 | +38.87 | +2.21% |
| PIVOT | 1746.13 | -12.27 | -0.70% |
| CURRENT | 1758.40 | — | — |
| S1 | 1707.27 | -51.13 | -2.91% |
| S2 | 1656.13 | -102.27 | -5.82% |
| S3 | 1617.27 | -141.13 | -8.03% |
| S4 | 1527.27 | -231.13 | -13.14% |
EVONILE is trading Above CPR, indicating Bullishness
CPR is Wider, suggesting unlikely for trending moves
Day's range: ₹1695–₹1750
Trading Above opening range, showing Bullishness
EVONILE PHARMA financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for EVONILE PHARMA — consolidated or standalone — with margins, YoY growth and key ratios inline.
EVONILE PHARMA reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹4,232.74 Cr..
EVONILE PHARMA segment analysis : revenue and profit mix.
Disclosed business segments at EVONILE PHARMA with their share of revenue and profit, switchable between consolidated and standalone reporting.
EVONILE PHARMA discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for EVONILE PHARMA.
Our AI distills the core fundamental drivers supporting EVONILE PHARMA, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
What you're getting.
No strengths or opportunities on record.
Key Risks.
No weaknesses or threats on record.
Flip Conditions.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
EVONILE PHARMA peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — EVONILE PHARMA is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
EVONILE PHARMA chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for EVONILE PHARMA — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
EVONILE PHARMA delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for EVONILE PHARMA over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in EVONILE PHARMA stood at 76.8% of traded volume, against a 20-day average of 65.2%.
EVONILE PHARMA announcements: results, concalls, ratings, M&A.
Filings EVONILE PHARMA sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
No filings or concall transcripts on record.
EVONILE PHARMA dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue EVONILE PHARMA has declared, sequenced by announce and record date.
EVONILE PHARMA corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About EVONILE PHARMA: business, sector, key facts.
What EVONILE PHARMA does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
EVONILE PHARMA is a listed Indian equity.
EVONILE PHARMA
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- 3B BLACKBIO DX (3BBLACKBIO) Share PricePeer
- ABBOTT INDIA (ABBOTINDIA) Share PricePeer
- ACUTAAS CHEMICALS (ACUTAAS) Share PricePeer
- ANLON HEALTHCARE (AHCL) Share PricePeer
- AMANTA HEALTHCARE (AMANTA) Share PricePeer
- Stocks near 52-week high (breakout watch)Screener
- Breakout Trader strategy playbookStrategy
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
Questions investors ask about EVONILE PHARMA (EVONILE).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of EVONILE PHARMA (EVONILE)?
The current share price of EVONILE PHARMA (EVONILE) is ₹1,758.40. Today, the stock has gained by ₹41.90 (2.44%), trading in a range of ₹1,695.00 to ₹1,785.00. The stock opened at ₹1,701.00 with a trading volume of 52,654 shares.
02Is EVONILE PHARMA stock a good investment for long-term?
EVONILE PHARMA can be considered for long-term investment based on several factors. The company has a market capitalization of ₹4,232.74 Cr., P/E ratio of 0, ROE of 0%, and ROCE of 0%. The dividend yield stands at 0%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of EVONILE PHARMA stock?
The 52-week high price of EVONILE PHARMA (EVONILE) is ₹1,738.00, while the 52-week low is ₹1,600.10. Currently trading at ₹1,758.40, the stock is 9.89% above its 52-week low and -1.17% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy EVONILE PHARMA stock at the current price?
Whether to buy EVONILE PHARMA stock at ₹1,758.40 depends on multiple factors. The stock is currently trading with a P/E ratio of 0 and P/B ratio of 0. Today's performance shows a gain of 2.44%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of EVONILE PHARMA and when is the next dividend?
EVONILE PHARMA offers a dividend yield of 0%, which means for every ₹100 invested at the current price of ₹1,758.40, you can expect to receive approximately ₹0.00 annually as dividends. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06How is EVONILE PHARMA stock performing today in the market?
EVONILE PHARMA stock opened at ₹1,701.00 and is currently trading at ₹1,758.40, showing a gain of ₹41.90 (2.44%). The intraday high is ₹1,785.00 and low is ₹1,695.00. The trading volume stands at 52,654 shares, indicating moderate market participation today.
07What is the market capitalization of EVONILE PHARMA?
EVONILE PHARMA has a market capitalization of ₹4,232.74 Cr., making it a small-cap company. Market cap is calculated by multiplying the current stock price (₹1,758.40) by the total number of outstanding shares. This metric helps investors understand the company's size, stability, and investment risk profile.
08What is the ROE and ROCE of EVONILE PHARMA?
EVONILE PHARMA has a Return on Equity (ROE) of 0% and Return on Capital Employed (ROCE) of 0%. ROE measures how efficiently the company generates profits from shareholders' equity, while ROCE indicates how well the company uses its capital to generate profits. These returns may need improvement for better profitability. Higher percentages generally indicate better financial performance.
The data, ratios and commentary about EVONILE PHARMA (EVONILE) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.